Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesca Romana Spinelli

Showing results (1-10 of 162) with videos related to

Pageof 17
Sort By:
Clinical and Experimental Rheumatology|August 29, 2013
Immunogenicity of anti-tumour necrosis factor drugs in rheumatic diseasesFrancesca Romana Spinelli, Guido Valesini
The Journal of International Medical Research|September 30, 2016
Foreword: Seminars in Research 2014 Joint Experiences in Rheumatology and DermatologyAntonio Costanzo, Francesca Romana Spinelli
Science Immunology|May 10, 2020
HiJAKing SARS-CoV-2? The potential role of JAK inhibitors in the management of COVID-19Francesca Romana Spinelli, Fabrizio Conti, Massimo Gadina
Rheumatology (Oxford, England)|July 12, 2019
Comment on: Temporal relationships between systemic lupus erythematosus and comorbiditiesFabrizio Conti, Fulvia Ceccarelli, Francesca Romana Spinelli
Rheumatology (Oxford, England)|May 5, 2021
JAK1: Number one in the family; number one in inflammation?Francesca Romana Spinelli, Robert A Colbert, Massimo Gadina
Arthritis and Rheumatism|April 29, 2008
Uveitis following the use of tumor necrosis factor alpha inhibitors: comment on the article by Lim et alRossana Scrivo, Antonio Spadaro, Francesca Romana Spinelli, et al.
The Journal of Rheumatology. Supplement|August 8, 2009
Monitoring biological therapies in psoriatic arthritisAntonio Spadaro, Rossana Scrivo, Francesca Romana Spinelli, et al.
Expert Review of Clinical Immunology|February 16, 2022
Affecting the effectors: JAK inhibitors modulation of immune cell numbers and functions in patients with rheumatoid arthritisCristina Garufi, Mary Maclean, Massimo Gadina, et al.
Clinical Reviews in Allergy & Immunology|July 3, 2010
Toll-like receptors and lupus nephritisFabrizio Conti, Francesca Romana Spinelli, Cristiano Alessandri, et al.
Annals of the Rheumatic Diseases|May 6, 2020
Response to 'To consider or not antimalarials as a prophylactic intervention in the SARS-CoV-2 (Covid-19) pandemic' by ParperisFrancesca Romana Spinelli, Fulvia Ceccarelli, Manuela Di Franco, et al.
Pageof 17

Showing results (1-10 of 162) with videos related to

Sort By:
Pageof 17
Clinical and Experimental Rheumatology|August 29, 2013
Immunogenicity of anti-tumour necrosis factor drugs in rheumatic diseasesFrancesca Romana Spinelli, Guido Valesini
The Journal of International Medical Research|September 30, 2016
Foreword: Seminars in Research 2014 Joint Experiences in Rheumatology and DermatologyAntonio Costanzo, Francesca Romana Spinelli
Science Immunology|May 10, 2020
HiJAKing SARS-CoV-2? The potential role of JAK inhibitors in the management of COVID-19Francesca Romana Spinelli, Fabrizio Conti, Massimo Gadina
Rheumatology (Oxford, England)|July 12, 2019
Comment on: Temporal relationships between systemic lupus erythematosus and comorbiditiesFabrizio Conti, Fulvia Ceccarelli, Francesca Romana Spinelli
Rheumatology (Oxford, England)|May 5, 2021
JAK1: Number one in the family; number one in inflammation?Francesca Romana Spinelli, Robert A Colbert, Massimo Gadina
Arthritis and Rheumatism|April 29, 2008
Uveitis following the use of tumor necrosis factor alpha inhibitors: comment on the article by Lim et alRossana Scrivo, Antonio Spadaro, Francesca Romana Spinelli, et al.
The Journal of Rheumatology. Supplement|August 8, 2009
Monitoring biological therapies in psoriatic arthritisAntonio Spadaro, Rossana Scrivo, Francesca Romana Spinelli, et al.
Expert Review of Clinical Immunology|February 16, 2022
Affecting the effectors: JAK inhibitors modulation of immune cell numbers and functions in patients with rheumatoid arthritisCristina Garufi, Mary Maclean, Massimo Gadina, et al.
Clinical Reviews in Allergy & Immunology|July 3, 2010
Toll-like receptors and lupus nephritisFabrizio Conti, Francesca Romana Spinelli, Cristiano Alessandri, et al.
Annals of the Rheumatic Diseases|May 6, 2020
Response to 'To consider or not antimalarials as a prophylactic intervention in the SARS-CoV-2 (Covid-19) pandemic' by ParperisFrancesca Romana Spinelli, Fulvia Ceccarelli, Manuela Di Franco, et al.
Pageof 17